search
Back to results

Evaluating Light Therapy for Treatment of Overuse Anterior Knee Pain (LLL&KP02)

Primary Purpose

Anterior Knee Pain Syndrome

Status
Completed
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
THOR Laser LX2 System
Sham Therapy
Sponsored by
Hebrew University of Jerusalem
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anterior Knee Pain Syndrome

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age: 18 - 65
  2. Knee pain on the background of overuse as determined by the orthopedic surgeon
  3. Willing to sign informed consent

Exclusion Criteria:

  1. Previous trauma to the knee
  2. Previous or planned surgical treatment to the knee
  3. Suspected meniscus injury
  4. Suffering from significant concurrent illness, such as cardiac disorders, or pertinent neurological disorders.
  5. Suffering from condition that does not permit filling questionnaires
  6. Use of NSAIDs during the 2 weeks before the development of Knee pain or before receiving treatment.

Sites / Locations

  • IDF bases

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Light Therapy

Sham Therapy

Arm Description

Subjects from this group will receive 8 biweekly physiotherapy treatment and in addition Light Therapy treatment with the THOR laser LX2 system.

Subjects from this group will receive 8 biweekly physiotherapy treatment and in addition Sham Therapy.

Outcomes

Primary Outcome Measures

Change from baseline to end of treatments in subjective pain level using a Visual Analogue Scale (VAS)
Subject assessment of pain will be evaluated using a Visual Analogue Scale (VAS), were 0 is "no pain" and 100 is "intolerable pain"

Secondary Outcome Measures

Change from baseline to 3 month follow up in subjective pain level using a Visual Analogue Scale (VAS)
Subject assessment of pain will be evaluated using a Visual Analogue Scale (VAS), were 0 is "no pain" and 100 is "intolerable pain"

Full Information

First Posted
July 24, 2016
Last Updated
August 8, 2019
Sponsor
Hebrew University of Jerusalem
Collaborators
Shaare Zedek Medical Center, International Diabetes Federation
search

1. Study Identification

Unique Protocol Identification Number
NCT02845869
Brief Title
Evaluating Light Therapy for Treatment of Overuse Anterior Knee Pain
Acronym
LLL&KP02
Official Title
Evaluation of the Efficacy of Light Therapy for the Treatment of Anterior Knee Pain: A Prospective, Randomized, Double-Blind, Sham-Controlled Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
March 1, 2017 (Actual)
Primary Completion Date
November 18, 2018 (Actual)
Study Completion Date
February 1, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hebrew University of Jerusalem
Collaborators
Shaare Zedek Medical Center, International Diabetes Federation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
During basic training, 15% of military recruits develop knee pain, which hinders their chance to complete training. Current therapeutic options have had variable levels of success. Light therapy was shown to reduce pain in chronic inflammatory related knee pathology. The current clinical study is designed to evaluate light therapy, as an adjunct to conservative physiotherapy for treatment of acute overuse KP in combat soldiers.
Detailed Description
During basic training, 15% of military recruits develop knee pain on the background of overuse, which hinders their chance to complete training, and leads to high dropout rate with the accompanying cost to the system. When KP is due to overuse, the time to complete resolution is typically 2-3 months, but symptoms may last for years. Current therapeutic options have had variable levels of success. Finding an alternative non-drug, non-invasive therapeutic modality that is easily incorporated in a field setting and may shorten the resolution of pain may lead to earlier return to duty thereby reducing the associated cost to the system and to the individual soldier. Low-level laser irradiation (LLLI) is non-ionizing and non-thermal, and is within the visible to near-infrared range of the electromagnetic spectrum. LLLI has been used widely for alleviation of pain, reduction of inflammation, and acceleration of wound healing. Pre-clinical and clinical studies have shown that LLLI reduces pain in chronic inflammatory related knee pathology. However, little is known about the effect of LLLI on acute knee pathology that account for 25-40% of all knee problems in athletes. The current study is a prospective, randomized, controlled double blind clinical study designed to evaluate light therapy, as an adjunct to conservative physiotherapy for treatment of acute overuse KP in combat soldiers. The treatment protocol includes conservative physiotherapy and in addition, biweekly sessions of light therapy or sham irradiation for 4 weeks. Two follow up visits will take place at 1 week and 3 months after the last treatment. Study evaluations will include physical examination, physical activity tests, subjective pain level by visual analogue scale, improvement and satisfaction scores, and functional questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anterior Knee Pain Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
85 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Light Therapy
Arm Type
Experimental
Arm Description
Subjects from this group will receive 8 biweekly physiotherapy treatment and in addition Light Therapy treatment with the THOR laser LX2 system.
Arm Title
Sham Therapy
Arm Type
Sham Comparator
Arm Description
Subjects from this group will receive 8 biweekly physiotherapy treatment and in addition Sham Therapy.
Intervention Type
Device
Intervention Name(s)
THOR Laser LX2 System
Intervention Description
Treatment session will take up to 25 minutes and will include stimulation of local lymph nodes and soft tissue, de-activation of trigger points, and eliciting analgesia.
Intervention Type
Device
Intervention Name(s)
Sham Therapy
Intervention Description
The therapeutic light will be turned off but the system will produce similar noises and mild heat.
Primary Outcome Measure Information:
Title
Change from baseline to end of treatments in subjective pain level using a Visual Analogue Scale (VAS)
Description
Subject assessment of pain will be evaluated using a Visual Analogue Scale (VAS), were 0 is "no pain" and 100 is "intolerable pain"
Time Frame
1 month (end of treatments)
Secondary Outcome Measure Information:
Title
Change from baseline to 3 month follow up in subjective pain level using a Visual Analogue Scale (VAS)
Description
Subject assessment of pain will be evaluated using a Visual Analogue Scale (VAS), were 0 is "no pain" and 100 is "intolerable pain"
Time Frame
3 month post treatments

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age: 18 - 65 Knee pain on the background of overuse as determined by the orthopedic surgeon Willing to sign informed consent Exclusion Criteria: Previous trauma to the knee Previous or planned surgical treatment to the knee Suspected meniscus injury Suffering from significant concurrent illness, such as cardiac disorders, or pertinent neurological disorders. Suffering from condition that does not permit filling questionnaires Use of NSAIDs during the 2 weeks before the development of Knee pain or before receiving treatment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yair Barzilay, MD
Organizational Affiliation
Shaare Zedek Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lilach Gavish, PhD
Organizational Affiliation
HUJI
Official's Role
Study Director
Facility Information:
Facility Name
IDF bases
City
Jerusalem
Country
Israel

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34101208
Citation
Gavish L, Spitzer E, Friedman I, Lowe J, Folk N, Zarbiv Y, Gelman E, Vishnevski L, Fatale E, Herman M, Gofshtein R, Gam A, Gertz SD, Eisenkraft A, Barzilay Y. Photobiomodulation as an Adjunctive Treatment to Physiotherapy for Reduction of Anterior Knee Pain in Combat Soldiers: A Prospective, Double-Blind, Randomized, Pragmatic, Sham-Controlled Trial. Lasers Surg Med. 2021 Dec;53(10):1376-1385. doi: 10.1002/lsm.23442. Epub 2021 Jun 8.
Results Reference
derived

Learn more about this trial

Evaluating Light Therapy for Treatment of Overuse Anterior Knee Pain

We'll reach out to this number within 24 hrs